Investigating biological activity spectrum for novel styrylquinazoline analogues

Molecules

Volumn 14, Issue 10, 2009, Pages 4246-4265

  Jampilek, Josef ^a,b   Musiol, Robert ^c   Finster, Jacek ^c   Pesko, Matus ^d   Carroll, James ^e   Kralova, Katarina ^d   Vejsova, Marcela ^f   O'Mahony, Jim ^e   Coffey, Aidan ^e   Dohnal, Jiri ^a,b   Polanski, Jaroslaw ^c  

^a Zentiva Prague   (Czech Republic)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^c UNIVERSITY OF SILESIA   (Poland)

^d Physics and Informatics   (Slovakia)

^e Munster Technological University   (Ireland)

^f Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

In vitro antifungal activity; In vitro antimycobacterial activity; Lipophilicity; PET inhibition; Spinach chloroplasts; Structure activity relationships; Styrylquinazolinone and styrylquinazoline derivatives

Indexed keywords

2 STYRYLQUINAZOLIN 4(3H) ONE; 2-STYRYLQUINAZOLIN-4(3H)-ONE; 4 CHLORO 2 STYRYLQUINAZOLINE; 4-CHLORO-2-STYRYLQUINAZOLINE; QUINAZOLINE DERIVATIVE; STYRENE DERIVATIVE; STYRYLQUINAZOLINE; TUBERCULOSTATIC AGENT;

ARTICLE; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL PNEUMONIA; CHEMISTRY; CHLOROPLAST; DRUG EFFECT; ELECTRON TRANSPORT; HUMAN; MICROBIOLOGY; PHOTOSYNTHESIS; SPINACH; SYNTHESIS;

ANTITUBERCULAR AGENTS; CHLOROPLASTS; ELECTRON TRANSPORT; HUMANS; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; PHOTOSYNTHESIS; PNEUMONIA, BACTERIAL; QUINAZOLINES; SPINACIA OLERACEA; STYRENES;

EID: 70350511014     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14104246     Document Type: Article

References (70)

1. Roth, H.J.; Fenner, H. Arzneistoffe, 3rd, ed.; Deutscher Apotheker Verlag: Stuttgart, Germany, 2000; pp. 51-114.
2. Harris, C.R.; Thorarensen, A. Advances in the discovery of novel antibacterial agents during the year 2002. Curr. Med. Chem. 2004, 11, 2213-2243.
3. Andries, K.; Verhasselt, P.; Guillemont, J.; Gohlmann, H.W.; Neefs, J.M.; Winkler, H.; Van Gestel, J.; Timmerman, P.; Zhu, M.; Lee, E.; Williams, P.; de Chaffoy, D.; Huitric, E.; Hoffner, S.; Cambau, E.; Truffot-Pernot, C.; Lounis, N.; Jarlier, V. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005, 307, 223-227.
4. Vangapandu, S.; Jain, M.; Jain, R.; Kaur, S.; Singh, P.P. Ring-substituted quinolines as potential anti-tuberculosis agents. Bioorg. Med. Chem. 2004, 12, 2501-2508. (Pubitemid 38542774)
5. Carta, A.; Piras, S.; Palomba, M.; Jabes, D.; Molicotti, P.; Zanetti, S. Anti-mycobacterial activity of quinolones. Triazoloquinolones a new class of potent anti-mycobacterial agents. Anti-Infective Agents Med. Chem. 2008, 7, 134-147.
6. Sissi, C.; Palumbo, M. The quinolone family: From antibacterial to anticancer agents. Curr. Med. Chem. Anti-Canc. Agents 2003, 3, 439-450.
7. Bossu, E.; Agliano, A.M.; Desideri, N.; Sestili, I.; Porra, R.; Grandilone, M.; Quaglia, M.G. LTB4 as marker of 5-LO inhibitory activity of two new N-ethoxycarbonyl-4-quinolones. J. Pharm. Biomed. Anal. 1999, 19, 539-549.
8. Ko, T.C.; Hour, M.J.; Lien, J.C.; Teng, C.M.; Lee, K.H.; Kuo, S.C.; Huang, L.J. Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents. Bioorg. Med. Chem. Lett. 2001, 11, 279-282.
9. Jampilek, J.; Dolezal, M.; Kunes, J.; Vichova, P.; Jun, D.; Raich, I.; ÓConnor, R.; Clynes, M. Synthesis of (2E)-2-methyl-3-(4-{[4-(quinolin-2- ylmethoxy)phenyl]sulfanyl}phenyl)prop-2-enoic acid (VUFB 20609) and 2-methyl-3-(4-{[4-(quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl) propionic acid (VUFB 20584) as potential antileukotrienic agents. J. Pharm. Pharmacol. 2004, 56, 783-794. (Pubitemid 38807302)
10. Jampilek, J.; Dolezal, M.; Kunes, J.; Vichova, P.; Jun, D.; Raich, I.; ÓConnor, R.; Clynes, M. Preparation of 2-(4-{[4-(quinolin-2-ylmethoxy) phenyl]sulfanyl}phenyl)propionic acid (VUFB 20615) and 2-methyl-2-(4-{[4- (quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl)propionic acid (VUFB 20623) as potential antileukotrienic agents. Curr. Org. Chem. 2004, 8, 1235-1243.
11. Jampilek, J.; Dolezal, M.; Opletalova, V.; Hartl. J. 5-Lipoxygenase, leukotrienes biosynthesis and potential antileukotrienic agents. Curr. Med. Chem. 2006, 13, 117-129.
12. Polanski, J.; Zouhiri, F.; Jeanson, L.; Desmaele, D.; d'Angelo, J.; Mouscadet, J.F.; Gieleciak, R.; Gasteiger, J.; Le Bret. M. Use of Kohonen neural network for rapid screening of ex vivo anti-HIV activity of styrylquinolines. J. Med. Chem. 2002, 45, 4647-4654.
13. Polanski, J.; Niedbala, H.; Musiol, R.; Tabak, D.; Podeszwa, B.; Gieleciak, R.; Bak, A.; Palka, A.; Magdziarz, T. Analogues of the styrylquinoline and styrylquinazoline HIV-1 integrase inhibitors: Design and synthetic problems. Acta Poloniae Pharm. Drug Res. 2004, 61, 3-4.
14. Polanski, J.; Niedbala, H.; Musiol, R.; Podeszwa, B.; Tabak, D.; Palka, A.; Mencel, A.; Finster, J.; Mouscadet, J.F.; Le Bret, M. 5-Hydroxy-8-nitro-6- quinaldic acid as a novel molecular scaffold for HIV-1 integrase inhibitors. Lett. Drugs Des. Disc. 2006, 3, 175-178.
15. Polanski, J.; Niedbala, H.; Musiol, R.; Podeszwa, B.; Tabak, D.; Palka, A.; Mencel, A.; Mouscadet, J.F.; Le Bret, M. Fragment based approach for the investigation of HIV-1 integrase inhibition. Lett. Drugs Des. Disc. 2007, 4, 99-105.
16. Jampilek, J.; Dolezal, M.; Kunes, J.; Buchta, V.; Kralova, K. Quinaldine derivatives: Preparation and biological activity. Med. Chem. 2005, 1, 591-599.
17. Musiol, R.; Jampilek, J.; Buchta, V.; Niedbala, H.; Podeszwa, B.; Palka, A.; Majerz-Maniecka, K.; Oleksyn, B.; Polanski, J. Antifungal properties of new series of quinoline derivatives. Bioorg. Med. Chem. 2006, 14, 3592-3598.
18. Musiol, R.; Jampilek, J.; Kralova, K.; Richardson, D.R.; Kalinowski, D.; Podeszwa, B.; Finster, J.; Niedbala, H.; Palka, A.; Polanski, J. Investigating biological activity spectrum for novel quinoline analogues. Bioorg. Med. Chem. 2007, 15, 1280-1288.
19. Musiol, R.; Tabak, D.; Niedbala, H.; Podeszwa, B.; Jampilek, J.; Kralova, K.; Dohnal, J.; Finster, J.; Mencel, A.; Polanski, J. Investigating biological activity spectrum for novel quinoline analogues 2: Hydroxyquinolinecarboxamides with photosynthesis inhibiting activity. Bioorg. Med. Chem. 2008, 16, 4490-4499.
20. Jampilek, J.; Musiol, R.; Pesko, M.; Kralova, K.; Vejsova, M.; Carroll, J.; Coffey, A.; Finster, J.; Tabak, D.; Niedbala, H.; Kozik, V.; Polanski, J.; Csollei, J.; Dohnal, J. Ring-substituted 4-hydroxy-1H-quinolin-2-ones: Preparation and biological activity. Molecules 2009, 14, 1145-1159.
21. Podeszwa, B.; Niedbala, H.; Polanski, J.; Musiol, R.; Tabak, D.; Finster, J.; Serafin, K.; Wietrzyk, J.; Boryczka, S.; Mol, W.; Jampilek, J.; Dohnal, J.; Kalinowski, D.; Richardson, D.R. Investigating the antiproliferative activity of quinoline-5,8-dione analogues on tumour cell lines. Bioorg. Med. Chem. Lett. 2007, 17, 6138-6141.
22. Draber, W.; Tietjen, K.; Kluth, J.F.; Trebst, A. Herbicides in photosynthesis research. Angew. Chem. 1991, 3, 1621-1633.
23. Tischer, W.; Strotmann, H. Relationship between inhibitor binding by chloroplasts and inhibition of photosynthetic electron transport. Biochim. Biophys. Acta 1977, 460, 113-125.
24. Trebst, A.; Draber, W. Structure activity correlations of recent herbicides in photosynthetic reactions. In Advances in Pesticide Science; Greissbuehler H. Ed.; Pergamon Press: Oxford, UK, 1979; pp. 223-234.
25. Bowyer, J.R.; Camilleri, P.; Vermaas, W.F.J. In Herbicides, Topics in Photosynthesis, vol. 10. Baker N.R., Percival M.P. Eds.; Elsevier: Amsterdam, The Netherlands, 1991; pp. 27-85.
26. Kralova, K.; Sersen, F.; Kubicova, L.; Waisser, K. Inhibition of photosynthetic electron transport in spinach chloroplasts by 3-and 4-halogeno substituted benzanilides and thiobenzanilides. J. Trace Microprobe Techn. 2000, 18, 251-256.
27. Kralova, K.; Sersen, F.; Miletin, M., Dolezal, M. Inhibitory effects of substituted benzanilides on photosynthetic electron transport in spinach chloroplasts. Chem. Pap. 2002, 56, 214-217.
28. Dolezal, M.; Miletin, M.; Kunes, J.; Kralova, K. Synthesis and biological evaluation of some amides of pyrazine-2-carboxylic acids. Molecules 2002, 7, 363-373.
29. Dolezal, M.; Palek, L.; Vinsova, J.; Buchta, V.; Jampilek, J.; Kralova, K. Substituted pyrazinecarboxamides: synthesis and biological evaluation. Molecules 2006, 11, 242-256.
30. http://www.who.int/tb/publications/global-report/2008/summary/en/index. html/ (21 September 2009).
31. Espinal, M.A. The global situation of MDR-TB. Tuberculosis 2003, 83, 44-51.
32. Field, S.K.; Cowie, R.L. Lung disease due to the more common nontuberculous mycobacteria. Chest 2006, 129, 1653-1672.
33. Wagner, D.; Young, L.S. Nontuberculous mycobacterial infections: A clinical review. Infection 2004, 32, 257-270.
34. Morrone, N.; Cruvinel, M.C.; Morrone, N. Jr.; Freire, J.A.; Oliveira, L.M.; Gonçalves, C. Pneumopatia causada por Mycobacterium kansasii. J. Pneumol. 2003, 29, 341-349.
35. http://www.doctorfungus.org/ (21 September 2009).
36. Gershon, H; Gershon, M; Clarke, D.D. Synergistic mixtures of fungitoxic monochloro- and dichloro-8-quinolinols against five fungi. Mycopathologia 2004, 158, 131-135.
37. Dardari, Z.; Lemrani, M.; Bahloul, A.; Sebban, A.; Hassar, M.; Kitane, S.; Berrada, M.; Boudouma, M. Antileishmanial activity of a new 8-hydroxyquinoline derivative designed 7-[5'-(32 -phenylisoxazolino)methyl]-8- hydroxyquinoline: preliminary study. Farmaco 2004, 59, 195-199.
38. Musiol, R.; Podeszwa, B.; Finster, J.; Niedbala, H.; Polanski; J. An efficient microwave-assisted synthesis of structurally diverse styrylquinolines. Monatsh. Chem. 2006, 137, 1211-1217.
39. Musiol, R.; Niedbala, H.; Majerz-Maniecka, K.; Oleksyn, B.; Polanski, J. Synthesis and structure of styrylquinolines. Ann. Pol. Chem. Soc. 2005, 1, 118-122.
40. Majerz-Maniecka, K.; Musiol, R.; Nitek, W.; Oleksyn, B.; Mouscadet, J.F.; Le Bret, M.; Polanski J. Intermolecular interactions in the crystal structures of potential HIV-1 integrase inhibitors. Bioorg. Med. Chem. Lett. 2006, 16, 1005-1009.
41. Kerns, E.H.; Li, D. Drug-like Properties: Concept, Structure Design and Methods. Elsevier: San Diego, CA, USA, 2008.
42. Avdeef, A. Physicochemical profiling (permeability, solubility, charge state). Curr. Topics Med. Chem. 2001, 1, 277-351.
43. Pliska, V. Lipophilicity in drug action and toxicology. In Methods and Principles in Medicinal Chemistry, 1st ed.; Pliska, V., Testa, B., van der Waterbeemd, H. Eds.; Wiley-VCH: Weinheim, DE, 1996; Vol. 4, pp. 1-6.
44. Valko, K. Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution. J. Chromatogr. A 2004, 1037, 299-310.
45. 22H). Curr. Med. Chem. 2001, 8, 1137-1146. (Pubitemid 32633663)
46. Cimpan, G.; Irimie, F.; Gocan, S.; Claessens, H.A. Role of stationary phase and eluent composition on the determination of log P values of N-hydroxyethylamide of aryloxyalkylen and pyridine carboxylic acids by reversed-phase high-performance liquid chromatography. J. Chromatogr. B 1998, 714, 247-261.
47. Gocan, S.; Cimpan, G.; Comer, J. Lipophilicity measurements by liquid chromatography. Adv. Chromatogr. 2006, 44, 79-176.
48. Hartmann, T.; Schmitt, J. Lipophilicity - beyond octanol/water: A short comparison of modern technologies. Drug Discov. Today Technol. 2004, 1, 431-439.
49. Nasal, A.; Siluk, D.; Kaliszan, R. Chromatographic retention parameters in medicinal chemistry and molecular pharmacology. Curr. Med. Chem. 2003, 10, 381-426.
50. Piraprez, G.; Herent, M.F.; Collin, S. Determination of the lipophilicity of aroma compounds by RP-HPLC. Flavour Fragr. J. 1998, 13, 400-408.
51. Yamagami, C.; Iwasaki, K.; Ishikawa, A. Hydrophobicity parameters determined by reversedphase liquid chromatography. XII. Comparison of capacity factors and octane/methanol-water partition coefficients for monosubstituted pyrazines, and effect of octanol added to both partitioning systems. Chem. Pharm. Bull. 1997, 45, 1653-1658.
52. Yamagami, C.; Araki, K.; Ohnishi, K.; Hanasato, K.; Inaba, H.; Aono, M.; Ohta, A. Measurement and prediction of hydrophobicity parameters for highly lipophilic compounds: Application of the HPLC column-switching technique to measurement of log P of diarylpyrazines. J. Pharm. Sci. 1999, 88, 1299-1304.
53. oct by using RP-HPLC procedures. Chem. Pharm. Bull. 2002, 50, 1578-1583.
54. Kucerova-Chlupacova, M.; Opletalova, V.; Jampilek, J.; Dolezel, J.; Dohnal, J.; Kunes, J.; Pour, M.; Kunes, J.; Vorisek, V. New hydrophobicity constants of substituents in pyrazine rings derived from RP-HPLC Study. Collect. Czech. Chem. Comm. 2008, 73, 1-18.
55. Musiol, R.; Jampilek, J.; Podeszwa, B.; Finster, J.; Tabak, D.; Dohnal, J.; Polanski, J. RP-HPLC Determination of drug lipophilicity in series of quinoline derivatives. Cent. Eur. J. Chem. 2009, 7, 586-597.
56. Dolezal, M.; Jampilek, J.; Osicka, Z.; Kunes, J.; Buchta, V.; Vichova, P. Substituted 5-aroylpyrazine-2-carboxylic acid derivatives: Synthesis and biological activity. Farmaco 2003, 58, 1105-1111.
57. Jampilek, J.; Vinsova, J.; Dohnal, J. Synthesis and hydrophobic properties of benzoxazoles. In Proceedings of the 9th International Electronic Conference on Synthetic Organic Chemistry (ECSOC-9), November 1-30, 2005 [CD-ROM ed.]; Seijas, J.A., Tato, M.P.V., Eds.; MDPI: Basel, Switzerland, 2005; a008.
58. Jampilek, J.; Vinsova, J.; Dohnal, J. Synthesis and hydrophobic properties of substituted 2-aryl- 5,7-di-tert-butylbenzoxazoles. In Proceedings of the 10th International Electronic Conference on Synthetic Organic Chemistry (ECSOC-10), November 1-30, 2006 [CD-ROM ed.]; Seijas, J.A., Tato, M.P.V., Eds.; MDPI: Basel, Switzerland, 2006; a003.
59. Vinsova, J.; Cermakova, K.; Tomeckova, A.; Ceckova, M.; Jampilek, J.; Cermak, P.; Kunes, J.; Dolezal, M.; Staud, F. Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tertbutylbenzoxazoles. Bioorg. Med. Chem. 2006, 14, 5850-5865.
60. Norrington, F.E.; Hyde, R.M.; Williams, S.G.; Wotton, R. Physicochemical-activity relations in practice. 1. Rational and self-consistent data bank. J. Med. Chem. 1975, 18, 604-607.
61. Takahata, Y.; Chong, D.P. Estimation of Hammett sigma constants of substituted benzenes through accurate density-functional calculation of core-electron binding energy shifts. Int. J. Quantum Chem. 2005, 103, 509-515.
62. Nielsen, K.E.; Pedersen, E.B. Phosphoramides. XII. Phosphorus pentaoxide - amine hydrochloride as reagents in the synthesis of 4-(3H)-quinazolinones and 4-quinazolinamines. Acta Chem. Scand. Ser. B 1980, 34, 637-642.
63. Finster, J.; Kalinowski, D.; Musiol, R.; Mrozek, A.; Szurko, A.; Serafin, A.; Kamalapuram, S.K.; Kovacevic, Z.; Jampilek, J.; Ratuszna, A.; Rezeszowska-Wolny, J.; Richardson, D.R.; Polanski, J. Investigating anti-proliferative activity of styrylazanaftalenes and azanaftalenediones. Bioorg. Med. Chem. 2009, submitted.
64. Kovalenko, S.; Belenichev, I.; Nikitin, V.; Karpenko, A. Search for substances with antioxidant and antiamnestic activities among 2-substituted 4-(3H)-quinazolones. Acta Pol. Pharm. Drug Design 2003, 60, 275-279.
65. Botros, S.; Shaban, M. Synthesis of some 2-styrylquinazoline derivatives structurally related to certain chemotherapeutic agents. Pharmazie 1978, 33, 646-647.
66. Masarovicova, E.; Kralova, K. Approaches to measuring plant photosynthesis activity. In Handbook of Photosynthesis, 2nd Ed.; Pessarakli, M., Eds.; Taylor & Francis Group: Boca Raton, London-New York-Singapore, 2005; pp. 617-656.
67. Kralova, K.; Sersen, F.; Sidoova, E. Photosynthesis inhibition produced by 2-alkylthio-6-Rbenzothiazoles. Chem. Pap. 1992, 46, 348-350.
68. Fedke, C. Biochemistry and Physiology of Herbicide Action; Springer Verlag: Berlin- Heidelberg/New York, Germany/US, 1982.
69. Sheehan, D.J.; Espinel-Ingroff, A.; Steele, M.; Webb, C.D. Antifungal susceptibility testing of yeasts: A brief overview. Clin. Infect. Dis. 1993, 17, 494-500.
70. National Committee for Clinical Laboratory standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. Approved Standard, NCCLS document M27-A; NCCLS: Villanova, PA, USA, 1997.